Nucletron B.V.
Nucletron is a global leader in the development, manufacture, sales, service
and support of the world's most innovative products for cancer treatment,
with particular expertise in treatment planning systems, brachytherapy,
simulation, integrated software solutions for oncology, and comprehensive
support and professional education and services. The company has over 20
offices worldwide, including its corporate headquarters in Veenendaal, the
Netherlands.
Nucletron B.V. is a subsidiary of Delft Instruments. Delft Instruments is
the holding company of an international group of companies, which hold a
leading position in their respective markets with high quality, high
technology products and services.
Delft Instruments is active through wholly
owned subsidiaries in more than 30 countries worldwide, employs
approximately 1,000 people and reported turnover of EUR 261.6 million in
2004.
Nucletron website: www.nucletron.com
Delft Instruments website:www.delftinstruments.com
|